USA Europe Asia
Compass AI Login Medtech Pro Login
  • Events
      Featured
      Our Next Event
      Register for LSI USA ‘26
      500+ Investors & Strategics
      See LSI USA '26 Attendee List
      Events Overview
      • Our Summits
      • Who Attends
      • Why Present
      Upcoming Summits
      • LSI USA ‘26
      • LSI Asia ‘26
      • LSI Europe '26
      Past Summits
      • LSI USA ‘25
      • LSI Asia ‘25
      • LSI Europe ‘25
      • Archives
  • Insights
      Featured
      Just Launched
      Compass AI
      New Report
      Emerging Innovators Report
      Compass Al
      Emerging Innovators Report
      Market Data
      Custom Research
  • Magazine
      Featured
      February Edition
      Explore Latest Editions
      The Lens Magazine
      Start Your Subscription
      Magazine
      • The Lens Magazine
      • Explore the Newest Edition
      • Read Free Articles
  • Resources
      Featured
      Released Weekly
      The LSI Alumni Weekly Recap
      Just Released
      2025 LSI Alumni Funding Report
      Resources
      • Research Desk
      • Testimonials
      • Video Library
      • Photo Gallery
  • Company
      Featured
      Our Next Event
      Register for LSI USA '26
      Just Launched
      Compass AI
      Company
      • About Us
      • Our Team
      • Press
  • Contact Us
Contact Us
USA Europe Asia
Compass AI Login Medtech Pro Login
  • Events
  • Insights
  • Magazine
  • Resources
  • Company
Events Overview
  • Our Summits
  • Who Attends
  • Why Present
Upcoming Summits
  • LSI USA ‘26
  • LSI Asia ‘26
  • LSI Europe ‘26
Past Summits
  • LSI USA ‘25
  • LSI Asia ‘25
  • LSI Europe ‘25
  • Archives
Featured
Our Next Event
Register for LSI USA '26
350+ Investors & Strategics
See LSI USA '26 Attendee List
Compass Al
Emerging Innovators Report
Market Data
Custom Research
Featured
Just Launched
Compass AI
New Report
Emerging Innovators Report
Magazine
The Lens Magazine
Explore the Newest Edition
Read Free Articles
Featured
February Edition
Explore Latest Editions
The Lens Magazine
Start Your Subscription
Resources
Research Desk
Testimonials
Video Library
Photo Gallery
Featured
Released Weekly
The LSI Alumni Weekly Recap
Just Released
2025 LSI Alumni Funding Report
Company
About Us
Our Team
Press
Featured
Our Next Event
Register for LSI USA '26
Just Launched
Compass AI
Join our Next Event
LSI USA ‘26, March 16-20, 2026
Waldorf Astoria, Monarch Beach
Register Today
Compass AI
The medtech-specific AI
research platform by LSI
Demo Compass AI
The Lens Magazine
The Lens Medtech
Magazine is LSI's most
curated industry coverage.
  1. Video Library
  2. CEO Spotlight: Leadership, Innovation, & Raising Capital in a Challenging Market | LSI Europe '22

CEO Spotlight: Leadership, Innovation, & Raising Capital in a Challenging Market | LSI Europe '22

This panel will explore the innovation and capital raising paths of 4 leading innovators featured at LSI Europe.
Share social-facebook social-x social-linkedin
Speakers
Carolina Aguilar
Carolina Aguilar
CEO, InBrain Neuroelectronics
Bio Bio
Bryan Lord
Bryan Lord
CEO, Pristine Surgical
Bio Bio
Abtihal Raji-Kubba
Abtihal Raji-Kubba
CEO, Empress Medical
Bio Bio
Berk Tas
Berk Tas
CEO, SentiAR
Bio Bio
Scott Pantel
Scott Pantel
CEO, LSI
Bio Bio
View Video Transcript
lsi logo
Contact Us

Upcoming Events

LSI USA ‘26
LSI USA ‘26
March 16-20, 2026
Dana Point, CA
LSI ASIA ‘26
LSI ASIA ‘26
June 30 - July 2, 2026
Singapore
LSI EUROPE ‘26
LSI EUROPE ‘26
Sept 28 - Oct 1, 2026
Barcelona

More From LSI

  • Attend an Event
  • Sponsor an Event
  • Compass, by LSI
  • The Lens, Magazine by LSI

Resources

  • Research Desk
  • Photo Gallery
  • Video Library
  • Testimonials
  • About Us

17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647

714-847-3540

© 2026 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy

Request Info
close
STEP 1
close-icon
The Lens - Complimentary Issue
close
close

Subscription Includes

Request Info

Global Medtech Market Analysis & Projections (MAP), 2021-2031
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf report

The Global Medtech Market Analysis and Projections (MAP) provides global market forecasts (2021 – ’31), share-by-supplier data, and analyst insights on 23 major device markets (e.g., Cardiovascular, Orthopedics, Neurovascular, In-Vitro Diagnostics) and 200+ technology subsegments. Understand major market trends and projections across the medtech industry with what medtech strategics and consulting firms have referred to as their “gold standard” for device market sizing data.

Global Surgical Procedure Volumes Dashboard, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Global Surgical Procedure Volumes database is the single source of truth for understanding diagnostic and therapeutic procedure volumes on a global scale. With coverage on 37 countries, including the United States, Europe’s Big Five, China, India, Japan and more for 12 major procedure markets (Cardio, Ortho, General Surgery, Radiosurgery, Neuro, OB/GYN and more), this fully interactive database is designed to facilitate one-to-one analyses of procedures, countries, and regions. Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

United States Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The United States Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for the United States. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Aesthetics, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Aesthetics Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Aesthetics Procedures Database covers major aesthetic procedures, including: Biopsies, Punch Biopsies, Shave Biopsies, Incisional Biopsies, Lesion Removal Procedures, Curettage, electrocautery, and electrocoagulation lesion destruction, Photodestruction, Cryotherapy-based lesion destruction, Lesion Removal Procedures: Traditional and Other, Abdominoplasty, Blepharoplasty, Breast Augmentation, Breast Lift, Breast Reduction, Buttock Augmentation, Buttock Lift, Cheek Implants, Chin Augmentation, Facelift, Forehead Lift, Gynecomastia Treatment, Hair Transplantation, Lip Augmentation, Liposuction, Lower Body Lift, Otoplasty, Rhinoplasty, Thigh Lift, Upper Arm Lift, Vaginal Rejuvenation, Surgeries for Cleft Palate and Lip, Surgeries for Burn Injuries.

Cardio, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Cardiothoracic and Interventional Cardiology Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Cardiothoracic and Interventional Cardiology Procedures Database covers major cardiothoracic and interventional cardiology procedures, including: CABG Surgeries Off-Pump CABG, On-Pump CABG, Valve Procedures Aortic Valve Replacements, Mitral Valve Replacements, MV Repairs, AV Repairs, PV Replacements, PV Repairs, TV Operations, Percutaneous Valvuloplasties, Percutaneous Valve Replacements, CHD Surgeries Ventricular Septal Defect Closures, Patent Ductus Arteriosus Repairs, Atrial Septal Defect Closures, Repair of Tetralogy of Fallot, Arterial Shunts Surgeries, Atrioventricular Septal Defect Repairs, Transposition of Great Artery Procedures, Anomalous Pulmonary Venous Return Repairs, Other Congenital Heart Disease Surgeries, Other Cardiothoracic Surgeries Aortic Aneurysm Procedures, Other Cardiothoracic Surgeries, Diagnostic and Therapeutic Catheterizations, Stand-Alone Diagnostic Cardiac Catheterizations, Percutaneous Coronary Interventions, Coronary Interventions Radial Approach, Coronary Interventions Femoral Approach, Heart Rhythm Procedures Conventional Pacemaker Procedures, ICD Procedures, Cardiac Resynchronization Device Procedures, Combined Defib/Resynch Device Procedures, Cardiac Ablations.

ENT, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Ear, Nose, and Throat Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Ear, Nose, and Throat Surgical Procedures Database covers major ear, nose, and throat procedures, including: Tonsillectomies, Operations on the Ear, FESS, Tracheostomies, Thyroidectomies & Parathyroidectomies, Stand-Alone Adenoidectomies, Tongue Operations, Laryngeal Operations, Pharyngeal Operations, Radical Neck Dissection.

General, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The General Surgeries Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The General Surgeries Procedures Database covers major general surgical procedures, including: Cholecystectomies Laparoscopic Cholecystectomies, Open Cholecystectomies, Appendectomies, Laparoscopic Appendectomies, Open Appendectomies, Herniorrhaphies Laparoscopic Herniorrhaphies, Open Herniorrhaphies, Bariatric Surgeries Laparoscopic Bariatric, Open Bariatric, Selected Other Endoscopic General & Colorectal Procedures Esophageal (Other Endoscopic), Stomach & Intestinal (Other Endoscopic), Colorectal (Other Endoscopic), Liver (Other Endoscopic), Gallbladder & Biliary (Other Endoscopic), Pancreatic (Other Endoscopic), Other (Other Endoscopic), Other Surgeries Esophageal (Other General, non-Endoscopic), Stomach & Intestinal (Other General, non-Endoscopic), Colorectal (Other General, non-Endoscopic), Liver (Other General, non-Endoscopic), Gallbladder & Biliary (Other General, non-Endoscopic), Pancreatic (Other General, non-Endoscopic), Other (Other General, non-Endoscopic).

Neuro, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Neurosurgery Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Neurosurgery Procedures Database covers major neurosurgical procedures, including: Surgeries for Traumatic Brain Injuries, Ventricular & Shunt Surgeries, New Shunt Placements, Revision Shunt Surgeries, Endoscopic Third Ventriculostomies, Diagnostic Ventricular Endoscopies, Vascular Lesion Procedures, Vascular Lesion Surgeries, Vascular Lesion Coil Procedures, Pituitary Tumor Surgeries, Open Pituitary Tumor Surgeries, Endoscopic Pituitary Tumor Surgeries, Intracranial Tumor Surgeries, Open Intracranial Tumor Surgeries, Endoscopic Intracranial Tumor Surgeries, Cranioplasties, Intracranial Neurostimulation and Peripheral Nerve Procedures, Intracranial Neurostimulator Implant Procedures, Peripheral Nerve Neurostimulation Procedures, Other Peripheral Nerve Procedures.

OB/GYN, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Obstetric and Gynecological Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Obstetric and Gynecological Surgical Procedures Database covers major obstetric and gynecological procedures, including: Obstetrical Surgeries Cesarean Sections, Destructive Operations, Episiotomies, Other Obstetrical Surgeries, Gynecological Surgeries Colposcopies, Hysterectomies, Salpingo-Oophorectomies & Oophorectomies, Colposcopies, Salpingo-Oophorectomies & Oophorectomies, Hysterectomies, Total Hysterectomies, Subtotal Hysterectomies, Vaginal Hysterectomies, Breast Cancer Surgeries, Breast Reconstruction Surgeries, Breast-Conserving Surgeries, and Mastectomies, among other surgeries.

Ophthalmology, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Ophthalmological Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Ophthalmological Surgical Procedures Database covers major ophthalmological procedures, including: Cataract Surgeries, Phacoemulsification Surgeries, ICCE Surgeries, ECCE Surgeries, MSICS Surgeries, Refractive Surgeries.

Orthopedic, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Orthopedic Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Orthopedic Surgical Procedures Database covers major orthopedic procedures, including: Hip Arthroplasties Revision Hip Arthroplasties, Hip Resurfacing Procedures, Primary Hip Arthroplasties - Total Hip, Partial Hip, Knee Arthroplasties Revision Knee Arthroplasties, Primary Knee Arthroplasties - Partial Knee, Primary Knee Arthroplasties - Total Knee, Extremity Fractures Using Hardware Extremity Fractures Using Hardware - Upper Extremities, Extremity Fractures Using Hardware - Fractures of the Femoral Neck & Shaft, Extremity Fractures Using Hardware - Other Lower Extremity, Arthroscopies Knees (Arthroscopies), Shoulders (Arthroscopies), Ankles (Arthroscopies), Feet & Toes (Arthroscopies), Others (Arthroscopies), Other Joint Arthroplasties Finger & Hand, Wrist, Elbow, Shoulder, Ankle & Foot.

Peripheral Vascular, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Peripheral Vascular Surgeries Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Peripheral Vascular Surgeries Procedures Database covers major peripheral vascular procedures, including: Arterial Procedures Thrombectomies & Thromboendarterectomies, Carotid Artery Thrombectomies, Upper Limb Artery Thrombectomies, Iliac Artery Thrombectomies, Renal Artery Thrombectomies, Lower Limb Artery Thrombectomies, Arterial Angioplasties, Carotid Artery Angioplasties, Upper Limb Artery Angioplasties, Iliac Artery Angioplasties, Renal Artery Angioplasties, Lower Limb Artery Angioplasties, Arterial Bypasses, Carotid Artery Bypasses, Upper Limb Artery Bypasses, Iliac Artery Bypasses, Renal Artery Bypasses, Aortofemoral and Aortobifemoral Bypasses, Femoropopliteal Bypasses, Femorotibeal Bypasses, Other Lower Limb Bypasses, Venous Procedures Head, Neck, & Upper Limb Thrombectomies & Thromboendarterectomies of Dialysis Access Venous Segments, Thrombectomies & Thromboendarectomies of Other Upper Limb Veins, Angioplasties of Dialysis Access Venous Segments, Angioplasties of Head, Neck and Other Upper Limb Veins, Lower Limb Venous Procedures Removals of the Saphenous Vein, Removals of Other Veins of the Lower Limbs.

Spine, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Spine Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Spine Surgical Procedures Database covers major spine procedures, including: Cervical Spine Surgeries Cervical Spine Decompressions, Cervical Spine Discectomies, Cervical Spine Fusions, Cervical Spine Disc Replacements, Thoracic and Deformity Procedures Thoracic Spine Decompressions, Thoracic Spine Discectomies, Thoracic Spine Fusions, Instrumented Procedures for Deformities, Lumbar Procedures Lumbar Spine Decompressions, Lumbar Spine Discectomies, Lumbar Spine Fusions, Insertion of Lumbar Interspinous Process Spacer, Lumbar Spine Disc Replacements, Vertebroplasties & Kyphoplasties Vertebroplasties, Kyphoplasties, Other Spine Surgeries.

SRS, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Stereotactic Radiosurgery Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Stereotactic Radiosurgery Procedures Database covers major stereotactic radiosurgery procedures, including: Intracranial SRS Procedures, Extracranial SRS Procedures, Extracranial Spine Procedures, Extracranial Lung Procedures, Other Extracranial Procedures.

Urological, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Urological Surgeries Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Urological Surgeries Procedures Database covers major urological procedures, including: Kidney Stone Procedures Extra Corporeal Shock Wave Lithotripsy, Percutaneous Nephro Lithotripsy, Ureteroscopies, Open Kidney Stone Procedures, BPH Procedures Transurethral Prostatectomies, Other BPH Surgeries, Prostatectomies, Nephrectomies Partial Nephrectomies, Radical Nephrectomies, Bladder Procedures Therapeutic Endoscopies, Diagnostic Endoscopies, Urethral Catheterizations of Bladder.

Global Markets for Hip Replacement Implants, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from LSI provides an analysis of the global market for hip replacement implants. The market for hip replacement implants includes all prosthetic devices used to replace damaged sections of the hip joint, including those used in total and semi/hemi replacement procedures. This market snapshot is intended to provide a high-level overview of the global market for hip replacement implants, with key insights into: Procedure volumes from 2022 to 2028, Market forecasts from 2022 to 2028, Competitive landscape analysis of major competitors, Insights into key market events for strategics and startups. Companies covered in this report include: B. Braun, DePuy Synthes, DJO Global, Exactech, Johnson & Johnson, Medacta, MicroPort Scientific, Ortho Development, OSSIS, SERF SAS, Smith+Nephew, Symbios Orthopedie, Total Joint Orthopedics, Zimmer Biomet.

Global Markets for Peripheral Vascular Guidewires, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Peripheral Atherectomy Catheters, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Electrosurgery, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Peripheral Vascular Balloons & Vena Cava Filter, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for percutaneous transluminal angioplasty (PTA) balloons and inferior vena cava (IVC) filters. A PTA balloon is used in the treatment of peripheral artery disease (PAD) to open a narrowed or blocked artery. IVC filters are permanent or temporary devices to prevent the travel of thrombotic material to the lungs. These devices are frequently used in the management of patients with severe PAD. This market snapshot is intended to provide a high-level overview of the global market for PTA balloons and IVC filters, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Abbott, Acotec Scientific, Adient Medical, B. Braun, BD, Biotronik, Boston Scientific, Brosmed, Cagent Vascular, Cardinal Health, CONMED, Cook Medical, Concept Medical, Cordis, Covellus, Degania Medical, iVascular, Medtronic, Merit Medical, NextStep Medical, Nipro, OrbusNeich, Orchestra BioMed, Philips, Terumo, TriReme Medical.

Global Markets for Mechanical Heart Valves, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Tissue Heart Valve Replacement, 2023-2028
Published:
2023
Next Update:
Q2 2030
Deliverables:
excel pdf

Description coming soon.

Global Markets for Transcatheter Mitral Valve Devices, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Femoral Closure, 2023-2029
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for femoral closure devices. Femoral closure devices are used to achieve hemostasis of the hole in the artery that is created to perform catheter-based cardiovascular or endovascular procedures. This market snapshot is intended to provide a high-level overview of the global market for femoral closure devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, Cardinal Health, Cardiva, Cordis, CyndRx, Endocor, Haemonetics, Morris Innovative, Rex Medical, Teleflex, Terumo, Transluminal Technologies, Vasorum, Vivasure Medical.

Global Markets for Tricuspid Valve Repair, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for tricuspid valve repair devices. Tricuspid valve repair is the preferred surgical approach for the treatment of degenerative tricuspid valve disease. The market is currently experiencing a renaissance with the introduction and development of transcatheter solutions for tricuspid valve repair and replacement. Devices covered within the scope of this analysis include tricuspid valve annuloplasty rings and transcatheter tricuspid valve repair devices. This market snapshot is intended to provide a high-level overview of the global market for tricuspid valve repair devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Abbott, CroiValve, Edwards Lifesciences, Innoventric, Medtronic, Mitral Holdco, Mitralix, NaviGate, OrbusNeich, TriCares, Venus Medtech.

Global Markets for Percutaneous Pulmonary Valves, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for transcatheter pulmonary valve devices. Pulmonary valve replacement is performed primarily for the treatment of pulmonary valve stenosis, a relatively rare disease associated with congenital heart defects. Devices covered within the scope of this analysis include transcatheter pulmonary valve implants for valve repair and replacement. This market snapshot is intended to provide a high-level overview of the global market for transcatheter pulmonary valve devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Edwards Lifesciences, Medtronic, PolyVascular, Venus Medtech.

Global Markets for Coronary Angio Guidewires & Catheters, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for coronary angiography catheters and guidewires. These devices are essential to perform coronary angiography, a minimally invasive medical procedure used to visualize blood flow, identify blockages and narrowing of the coronary arteries. Devices covered within the scope of this analysis include coronary angiography catheters and coronary angiography guidewires. This market snapshot is intended to provide a high-level overview of the global market for coronary angiography catheters and guidewires, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, AngioDynamics, B. Braun, Boston Scientific, Cardinal Health, Cook Medical, Cordis, Medtronic, Merit Medical, Philips, Teleflex, Terumo.

Global Markets for Oncology Ablation Devices, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for oncology ablation catheters. These devices are used as a therapeutic modality employing energy to selectively destroy cancerous tissue. Devices covered within the scope of this analysis include radiofrequency and microwave ablation electrodes, excluding cryoablation devices, which are covered in a separate report. The snapshot offers a high-level overview of the global market for oncology ablation catheters and guidewires, with key insights into unit volumes and market forecasts from 2023 to 2028, along with a competitive landscape analysis of major competitors and insights into key market events for strategics and startups. Companies covered in this report include: AngioDynamics, Baylis, Boston Scientific, Canyon Medical, CAPS Medical, EDAP, Galvanize Therapeutics, Imagin Medical, Medtronic, Mermaid, Mirai Medical, Monteris, Sonablate, Stryker, TROD Medical, and US Medical Innovations.

Global Markets for ENT Devices, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for endoscopic devices for ear, nose, and throat (ENT) surgery. These devices are used to examine and operate on the structures and tissues in the ear, nose, and throat. Devices covered within the scope of this analysis include ENT endoscopic surgical instruments, balloon sinus and dilation catheters, and rigid endoscopes and bronchoscopes. This market snapshot is intended to provide a high-level overview of the global market for ENT endoscopic surgery devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: 3NT Medical, Acclarent, Conmed, Endoluxe, Entellus Medical, Intuitive Surgical, Johnson & Johnson, KARL STORZ, Medtronic, Olympus, Pentax, Pristine Surgical, Richard Wolf, Smith & Nephew, Stryker, Tympany Medical.

Global Markets for Cell Delivery Catheters, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for cell delivery catheters. These devices are primarily research-use devices for the delivery of cellular therapies for the treatment of chronic diseases, such as cardiovascular disease and cancer. Devices covered within the scope of this analysis include cell delivery catheters. This market snapshot is intended to provide a high-level overview of the global market for cell delivery catheters, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: BioCardia, Biosense Webster, Boston Scientific, Cordis, Medtronic, Mercator MedSystems, TriSalus Life Sciences, TRI Medical.

Global Markets for Urology Devices, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence offers an analysis of the global market for urology and renal devices, focusing on treatments for six major conditions: End-stage renal disease (ESRD), Incontinence, Calculi (stones), Benign prostatic hyperplasia (BPH), Prostatitis, and Erectile dysfunction (ED). The devices covered within this analysis encompass a range of tools for diagnosis, treatment, and management, including urinary bags, foley catheters, catheter insertion kits, intermittent catheters, endourology devices, BPH ablation devices, lithotripsy devices, and artificial penis devices. The snapshot provides key insights into unit volumes and market forecasts spanning from 2023 to 2028. Additionally, it includes a competitive landscape analysis of major competitors and insights into key market events for strategics and startups. Companies covered in this report include: 3M, Applied Medical, Astratech, Balton, Baxter Healthcare, B. Braun, BD, Boston Scientific, Calyxo, Corinth Medtech, Coloplast, EndoMed, Flume Catheter Company, Hollister, ICU Medical, Karl Storz, Medline, Medtronic, Merit Medical, Nipro, Olympus, SonoMotion, Teleflex, and Urovision.

Global Markets for External Pain Pumps, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for external pain pumps. These devices are used to provide patients with consistent, long-lasting pain relief by delivering pain medication epidurally, intravenously, or subcutaneously. Devices covered within the scope of this analysis include external infusion pumps for pain management. This market snapshot is intended to provide a high-level overview of the global market for external pain pumps, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Avanos, B. Braun, BioQ Pharma, Epic Health, ICU Medical, InfuTronix, Medical Flow Systems, Medipacs, MicroPort, Smiths Medical, Teleflex.

Global Markets for Ureteral Access Devices, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence delves into the global market for ureteral access devices, crucial components utilized alongside ureteroscopy or percutaneous nephrolithotomy procedures. These devices facilitate dilation and create a working channel for various urologic interventions. The snapshot aims to offer insights into unit volumes and market forecasts spanning from 2023 to 2028. Additionally, it provides a competitive landscape analysis of major competitors and key market events for strategics and startups. Companies covered in this report include: Amecath, Applied Medical, BD, Boston Scientific, Cook Medical, Envaste, Johnson & Johnson, Mednova, Olympus, Richard Wolf, Rocamed, Teleflex, and Terumo.

Global Markets for Pelvic Floor Repair, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for pelvic floor repair mesh. These products are used during surgical procedures to repair prolapse and urinary incontinence. Devices covered within the scope of this analysis include pelvic floor repair/reconstruction mesh. This market snapshot is intended to provide a high-level overview of the global market for pelvic floor repair mesh, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: BD, Boston Scientific, Coloplast, Cook Medical, Ethicon, Johnson & Johnson.

Global Markets for Atrial Fibrillation, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Neurovascular Devices Ischemic, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This report from Life Science Intelligence analyzes the global market for devices used in the treatment of ischemic stroke, focusing on solutions designed to remove occlusions in blood vessels to prevent and treat this condition. The market snapshot offers insights into unit volumes and market forecasts from 2023 to 2028, along with a competitive landscape analysis of major competitors and key market events for strategics and startups. Companies covered in this report include: Cerenovus, Ceretrieve, Cordis, InNeuroCo, Julier, Medtronic, MicroPort Scientific, Microvention, Penumbra, Phenox, Poseydon Medical, Route 92 Medical, Stryker, and Terumo.

Global Markets for Neuromodulation Devices, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This report from Life Science Intelligence provides an analysis of the global neuromodulation market – a thriving market for managing and treating neurological diseases, chronic pain, and other chronic conditions. Types of neuromodulation, or neurostimulation, devices include implantable and transcutaneous devices, including wearable devices. This market snapshot is intended to provide a high-level overview of the global neuromodulation market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, Advanced Bionics, Alyve Medical, Axonics, Biotronik, Boston Scientific, EBT Medical, electroCore Medical, Inspire Medical, LivaNova, Medtronic, Neuromod Devices, Nevro.

Global Markets for Vertebroplasty Devices, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence offers an analysis of the global market for vertebral augmentation products, which are crucial in treating vertebral compression fractures, often caused by osteoporosis or spinal tumors. Vertebroplasty and kyphoplasty are the primary surgical interventions, and the market includes products such as vertebroplasty and kyphoplasty cement, as well as delivery devices. The snapshot aims to provide a comprehensive overview of the global vertebral augmentation products market, with key insights into unit volumes and market forecasts from 2023 to 2028. Additionally, it includes a competitive landscape analysis of major competitors and insights into key market events for both established players and startups. Companies covered in this report include: Halma, IZI Medical, Medtronic, Mendec, Merit Medical, RevBio, and Stryker.

Global Markets for TAVI/TAVR, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

Global Markets for Drug Delivery, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

Global Markets for Benign Prostation Hyperplasia Implants, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This report from Life Science Intelligence provides an analysis of the global market for implants for the treatment of symptomatic benign prostatic hypertrophy/hyperplasia (BPH). These implants are reversible solutions for men suffering from lower urinary tract symptoms (LUTS) caused by prostate enlargement. This market snapshot is intended to provide a high-level overview of the global BPH implants market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Butterly Medical, Endotherapeutics, Olympus, ProArc, ProVerum, Teleflex, Urotronic, ZenFlow.

Global Markets for Cryoablation, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This report from Life Science Intelligence provides an analysis of the global market for cryoablation devices for non-cardiovascular applications. These devices are used to freeze and induce cellular damage and death for indications including cancer, dermatological conditions, peripheral vascular disease, and urological conditions. This market snapshot is intended to provide a high-level overview of the global cryoablation devices market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Boston Scientific, Brymill Cryogenics, Channel Medsystems, CooperSurgical, CPSI Biotech, CryoConcepts, CryoProbe, CryoSurgery, CSA Medical, Endocare, Endocision, Grand Cryo, Ictero Medical, KryoLife, Mectronic Medical, Sedivention, Siemens Healthineers, Varian Medical Systems, Wallach Surgical.

Global Markets for Diagnostic Electrophysiology Catheters, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for diagnostic electrophysiology catheters. These devices are used to measure and map electrical activity within the heart to identify aberrant electrical activity that causes arrhythmias. LSI projects that this market will remain in a high growth phase due to improving technology for the surgical treatment of cardiac arrhythmias and atrial fibrillation (AF). This market snapshot is intended to provide a high-level overview of the global diagnostic electrophysiology catheters market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, AccuPulse, Acutus Medical, BD, Biosense Webster, Boston Scientific, CardioNXT, CoreMap, Johnson & Johnson, Kardium, Medtronic, MicroPort Scientific, Stereotaxis.

Global Markets for Hernia Repair, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence (LSI) provides an analysis of the global market for hernia mesh products for the surgical repair of hernias. The global market for hernia mesh products is projected to see moderate growth throughout the forecast period covered by the analysis. While the market has been negatively impacted by ongoing lawsuits associated with product complications, the next generation of products has helped the market to recover for one of the most performed abdominal surgeries. This market snapshot is intended to provide a high-level overview of the global market for hernia mesh products, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Allergan, Ariste Medical, BD, Cook Medical, Deep Blue Medical Advances, Ethicon, Exogenesis, Integra Lifesciences, Johnson & Johnson, LifeCell, Medtronic, Novus Scientific, Tarian Medical, TELA Bio, TISSIUM, W.L. Gore.

Global Markets for CRM Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for cardiac rhythm management (CRM) devices, including pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy devices (CRT-Ds). These implantable devices are used to restore the natural rhythm and function of the heart that can be impaired as a result of cardiac rhythm disorders and heart failure. This market snapshot is intended to provide a high-level overview of the global CRM devices market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, AtaCor Medical, BioTrace Medical, Biotronik, Boston Scientific, Cairdac, Electroducer, FineHeart, Lepu Medical, LivaNova, Medico, Medtronic, Merit Medical, Microport Scientific, Osypka Medical, Pacetronix.

Global Markets for Neurovascular Devices Hemorrhagic, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This report from Life Science Intelligence provides an analysis of the global market for neurovascular devices for the treatment of hemorrhagic stroke. These solutions are used to treat intracerebral bleeds, ruptured aneurysms, and other neurovascular deformities that lead to the pooling of blood vessels that have ruptured inside and outside of the brain. This market snapshot is intended to provide a high-level overview of the global market for neurovascular devices for hemorrhagic stroke, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Acandis, Artio Medical, Endostream Medical, Medtronic, MicroPort Scientific, Microvention, Phenox, Penumbra, Rapid Medical, Shape Memory Medical, Stryker, Terumo, Wallaby Medical.

Global Markets for Renal Denervation, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for renal denervation devices for the treatment of refractory hypertension (i.e., high blood pressure that does not respond to pharmaceuticals). The market for renal denervation devices includes radiofrequency and ultrasound catheters which are used to ablate the renal nerves. This market snapshot is intended to provide a high-level overview of the global market for renal denervation devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Ablative Solutions, Brattea, Medtronic, Metavention, Otsuka Medical, ReCor Medical, SoniVie.

Global Markets for Upper+Lower Suture Anchors, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence analyzes the global market for suture anchors used in upper and lower extremity repair and reconstruction procedures. Suture anchors play a critical role in securing soft tissue to bone, particularly for severe soft tissue tears. The market encompasses bioabsorbable, biocomposite, metallic, and PEEK suture anchors. The snapshot aims to offer insights into unit volumes and market forecasts from 2023 to 2028, along with a competitive landscape analysis of major competitors and key market events for strategics and startups. Companies covered in this report include: Acumed, Acuitive Technologies, aevumed, Anika Therapeutics, Arthrex, ConMed, DePuy Synthes, Johnson & Johnson, Mitek, OSSIO, Paragon 28, Responsive Arthroscopy, Riverpoint Medical, Smith & Nephew, Stryker, and Zimmer Biomet.

Global Markets for Peripheral Stents, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for biliary and peripheral vascular stents. These devices are used to maintain and restore patency to anatomical ducts or vessels that have become obstructed due to the formation of plaque, narrowing of the natural lumen, or presence of benign and malignant growths. This market snapshot is intended to provide a high-level overview of the global peripheral vascular and biliary stents market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Abbott, BD, Biotronik, Boston Scientific, Bryan Medical, Cardinal Health, Cook Medical, Cordis, Endo GI Medical, Hood Labs, Maquet, Medtronic, Merit Medical, MicroPort Scientific, Olympus, Q3 Medical, Zorion Medical.

Global Markets for Electromagnetic Navigation Systems, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for electromagnetic navigation systems for tracking, guiding, and positioning instruments during surgery. These systems provide surgeons and the surgical team with real-time information on the position and orientation of instruments used during open and minimally invasive surgeries. This market snapshot is intended to provide a high-level overview of the global electromagnetic navigation systems market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Brainlab, Collin Medical, Elucent Medical, Fiagon, Heal Force, Joimax, Karl Storz, Medtronic, Olympus, Stryker, Veran Medical Technologies.

Global Markets for GI Endoscopy, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot report from Life Science Intelligence provides an analysis of the global market for gastrointestinal (GI) endoscopic devices. These devices are used to visualize, diagnose, and surgically treat conditions of the GI tract. The market for GI endoscopic devices includes endoscopes and endoscopic instruments. This market snapshot is intended to provide a high-level overview of the global market for GI endoscopic devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Ambu, Applied Medical, Aqua Medical, Aspero Medical, B. Braun, Boston Scientific, ConMed, Endoluxe, Ethicon, Integra Lifesciences, Intuitive Surgical, IQ Endoscopes, Johnson & Johnson, Karl Storz, Medtronic, MiWendo Solutions, Olympus, Purple Surgical, Richard Wolf, Stryker, Teleflex.

Global Markets for Hemodialysis, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for hemodialysis solutions. Hemodialysis is an essential treatment for patients suffering from end-stage renal disease due to kidney failure. Hemodialysis systems, catheters, and dialyzers are components integral to hemodialysis treatment. This market snapshot is intended to provide a high-level overview of the global hemodialysis solutions market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Asahei Kasei, AngioDynamics, B. Braun, Baxter, Bellco, Byonyks, Diality, Fresenius, Hemoclean, Humacyte, Intermedt, Inspira Health, iRen-MEDICAL, Medivators, Merit Medical, NextKidney, Nikkiso, Nipro, Rockwell Medical, Telelfex, Terumo, Toray Medical, TVA Medical, Vantive.

Globals Markets for Cardiac Ablation, 2023-2028
Published:
Next Update:
Deliverables:

This market snapshot from Life Science Intelligence provides an analysis of the global market for cardiac ablation devices, which are used for the treatment of arrhythmic heart conditions, such as atrial fibrillation. The market for cardiac ablations devices is projected to see strong growth throughout the forecast period covered by this analysis, driven by demographic trends and the adoption of new technologies for the treatment of new ablation technologies, such as Pulsed Field Ablation. Devices covered within the scope of this analysis include cardiac ablation catheters. This market snapshot is intended to provide a high-level overview of the global market for cardiac ablation devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, Adagio Medical, AtriAN Medical, AtriCure, Biosense Webster, Boston Scientific, Electrophysiology Frontiers, Field Medical, Galvanize Therapeutics, Healium Medical, Johnson & Johnson, Medtronic, Stereotaxis.

Global Markets for Atrial Septal Occlusion, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for atrial septal occlusion devices. These devices are used to close atrial septal defects (ASDs), an abnormal hole in the wall of the upper chambers of the heart that are present at birth. This market snapshot is intended to provide a high-level overview of the global ASD occlusion devices market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, atHeart Medical, Cardia, Hanyu Medical, Lifetech Scientific, Occlutech, W.L. Gore.

Global Markets for Aortic Grafts, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from LSI provides an analysis of the global market for aortic stent grafts for the treatment of aortic aneurysm. The market for aortic stent grafts includes open (surgical) and endovascular (transcatheter) aortic stent grafts used in the repair of abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA). This market snapshot is intended to provide a high-level overview of the global market for aortic stent grafts, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Cook Medical, Endoron, Endospan, Lombard Medical, Medtronic, MicroPort Scientific, Taurus Vascular, Terumo, TripleMed, W.L. Gore.

Global Markets for Interventional Cardiology Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from LSI provides an analysis of the global market for interventional cardiology devices for the treatment of cardiovascular diseases such as heart failure or severe atherosclerosis. The market for interventional cardiology devices includes devices used to diagnose and treat diseases related to the coronary arteries. Devices included within the scope of this report include coronary stents, catheters, angioplasty balloons, guidewires, and intravascular ultrasound catheters. This market snapshot is intended to provide a high-level overview of the global market for interventional cardiology devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, Advanced Bifurcation Systems, B. Braun, BD, Boston Scientific, Cardinal Health, Cook Medical, Corflow Therapeutics, Fastwave Medical, Lemaitre Vascular, Medtronic, Merit Medical, MicroPort Scientific, NirvaMed, Philips, Teleflex, Terumo, Translumina.

Global Markets for Oncology Embolization, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for oncology embolization agents, including radioembolization, chemoembolization, and particle embolization devices. These solutions are used to occlude blood vessels to lesions and tumors to derive the target of nutrients, enhance the effectiveness of the targeted delivery of pharmaceuticals, and trigger cell death. This market snapshot is intended to provide a high-level overview of the global oncology embolization agents market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: ABK Biomedical, Arsenal Medical, Boston Scientific, Cook, Cordis/Cardinal Health, Instylla, Medtronic, Merit Medical, Ned Medical, Obsidio, SirTex Medical, Stryker, Terumo, Varian.

Global Markets for Vascular Access Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence offers an analysis of the global market for vascular access devices, which are essential for continuous and long-term access to the bloodstream for administering intravenous drugs and fluids. The market encompasses various types of devices, including peripherally inserted central catheters (PICC), midline catheters, central venous catheters (CVC), and implantable ports. The snapshot aims to provide a comprehensive overview of the global market for vascular access devices, offering key insights into unit volumes and market forecasts from 2023 to 2028. Additionally, it includes a competitive landscape analysis of major competitors and insights into key market events for both established players and startups. Companies covered in this report include: Access Vascular, AngioDynamics, B. Braun, Baxter, Becton, Dickinson & Company (BD), Bluegrass Vascular, C.R. Bard, Cook Medical, ICU Medical, Medline, Smiths Medical, Teleflex, Terumo, Vygon, and Yushin Medical.

Global Markets for Rotator Cuff Repair Suture Anchors, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from LSI provides an analysis of the global market for rotator cuff repair suture anchors for the treatment of rotator cuff injuries. The market for rotator cuff repair suture anchors includes anchors composed of biocompatible polymers and metals. This market snapshot is intended to provide a high-level overview of the global market for rotator cuff repair suture anchors, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Aevumed, Arthrex, Atreon Orthopedics, ConMed, DePuy Synthes, Embody, Inovedis, Smith & Nephew, Stryker, Tetrous, Wright Medical, Zimmer Biomet.

Global Markets for Electrical Stimulation Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Wearable Monitoring Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Low Complexity Medical Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

Description coming soon.

Canada Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Canada Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Canada. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Germany Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Germany Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Germany. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

France Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The France Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for France. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

U.K. Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The United Kingdom Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for the United Kingdom. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Italy Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Italy Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Italy. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Spain Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Spain Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Spain. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Poland Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Poland Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Poland. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Netherlands Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Netherlands Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for the Netherlands. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Belgium Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Belgium Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Belgium. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Sweden Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Sweden Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Sweden. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Switzerland Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Switzerland Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Switzerland. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Denmark Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Denmark Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Denmark. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Finland Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Finland Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Finland. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Norway Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Norway Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Norway. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

China Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The China Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for China. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

India Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The India Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for India. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Japan Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Japan Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Japan. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

South Korea Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The South Korea Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for South Korea. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Australia Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Australia Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Australia. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Thailand Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Thailand Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Thailand. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Malaysia Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Malaysia Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Malaysia. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Singapore Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Singapore Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Singapore. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

New Zealand Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The New Zealand Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for New Zealand. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Caribbean Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Caribbean Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for the Caribbean region. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Argentina Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Argentina Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Argentina. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Colombia Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Colombia Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Colombia. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Chile Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Chile Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Chile. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Guatemala Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Guatemala Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Guatemala. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Dominican Republic Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Dominican Republic Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for the Dominican Republic. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Costa Rica Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Costa Rica Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Costa Rica. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Panama Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Panama Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Panama. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Mexico Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Mexico Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Mexico. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Brazil Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Brazil Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Brazil. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Turkey Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Turkey Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Turkey. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Russia Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Russia Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Russia. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

South Africa Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The South Africa Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for South Africa. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.
Schedule Meeting
Request Info
close
Video Transcription
close

Transcription


Scott Pantel  0:04  


Thank you Welcome everyone, I just learned a valuable lesson. If you don't provide a bio, they're gonna copy and paste from your LinkedIn. And they're gonna read exactly what was there. But thank you for that. Thank you for that. I appreciate it. It's It's a honor to be here with this group of innovators here. And this is a session that I love to do. I've been to far too many meetings, maybe not too many, I think it's really important. But at these types of meetings, you'll often see on the stage, the investors who will share with everybody in the audience, what they're looking for, very important for us all to know. We'll have lineups of strategics, who will share what kind of deals they're looking for. Right. And we need all this information. And I think that we have a gap in the opportunities for us to bring the innovators up here, who are actually doing the work. And they're taking action to share what it is that they're doing. But also what they look for when they're looking for partners. And it's a really unique time. Right now. It's a challenging climate. I've shared this in the past that my heart is with everybody that's here. I love the medtech ecosystem. I love what we do collectively. But when it comes down to it, my hearts with this group, because they're the ones in my view that are taking the real chances out there. And so I'm with you all the way and the focus here is just to talk generally about what's going on in the environment, what you're seeing, we have a diverse group of technologies. So what I thought we'd do is we'll start with Burke, we'll work our way back. And if you could just introduce yourself and talk about your company where you're at right now. We'll go brief, and then we'll get through the details down the line.


 


Berk Tas  1:43  


Thank you. Thanks, Scott, for having us up here. It really is nice to see how you've become a partner of the startups that that we're all a part of. My name is Burke toss. I'm the CEO of SentiAR we're focused on our current development is focused in electrophysiology. And we're developing a augmented reality platform for holographic guidance, real time guidance. I know it's mouthful of what I'm saying just a quick explanation of what it is. It allows the physician who's operating in the heart as a minimally invasive procedure, allows them to see the heart in 3d in real time with the catheters inside. So they're able to navigate more accurately and more efficiently. That's our product. That's what we're up to. Thanks again, Scott.


 


Abtihal Raji-Kubba  2:35  


I'm Abtihal Raji-Kubba. I am president and CEO of Empress medical, Empress medical is a woman's health care company. Though my background is nothing to do with women's health care, the prevalence of the condition was truly an eye opening discovery for me and got me immediately hooked with the company. The company had already developed the product and ran a first in human study in Dominican Republic, where they showed a proof of feasibility of the treatment. Unlike the other treatments that are out there, starting with their very few options with women, for women with uterine fibroids to start with, for younger woman, especially women who want to to preserve their ability to have children the option to have children, the there are practically if there are any options, they are not great. Impressed medical is a game changer in the sense that it's introduced as a very simple simple technique, technology. However, the principles of it are very innovative. It doesn't involve any, you know, thermal energy nor risk associated with any any major surgery, no dissection. So it's truly truly compared to the other I'm not being biased through the I did that homework myself. Truly compared to the available options. It is we hope to show that it is one of the safest options that will become to women. I believe we owe it it's a it's a health public issue. I believe we owe we owe it to ourselves to woman our generation younger and the upcoming generations of woman. I hope that you will tomorrow when we present I hope you will see that you know we've made some progress in it. We plan to stay the course here. It's different. Everyone says where's your energy? How are you going to do this? We're sticking with the simple approach as being the safest and also the easiest to adopt by gynecologist. Very cool.


 


Bryan Lord  4:44  


Fantastic. Scott. Thanks again for having us. My name is Bryan Lord. I'm the CEO of Pristine Surgical, we make single use endoscopes and our mission is to simplify endoscopy and we do that really with two tools in our tool chest. First, we make single use scopes as mentioned And we put those into a single use kit, so sterilized at the factory and shipped them to our customers. And then we complement that with a cloud based software platform. So hardware and software, the two tools that we use, we have a couple of aspects to the software side one, we manage our inventory through what we call our pristine Connect platform, to we integrate a whole host of value added services, and then three, we actually facilitate the conversations with our Salesforce through our pristine connected platform as well. So simplifying, endoscopy basically, we make procedures faster, we make visualization better, and we lower costs. So it truly is a faster, better, cheaper option for our customers.


 


Carolina Aguilar  5:41  


Thank you. Again, my name is Carolina Aguilar. I'm the CEO of InBRAIN Neuroelectronics. And we are creating the first worldwide high density and high resolution intelligent neural system based on graphene. And it is a platform that we are starting with for Parkinson's disease. But we have also a partnership with Merck, to enter into bioelectronics in the very systemic conditions like anti inflammation. And in the last year from series, A, which was a significant raise for the European market $17 million, we were able with this money to actually prove the potential of the material in small animals in large animals. And now our next step is the first inhuman in cortical early next year.


 


Scott Pantel  6:30  


It's great. So we've got a diverse group of technologies. And I think in terms of stages of development, there's a mixture. But the one thing that we all have in common that you all have in common is that you're growing companies during challenging times. And it's not easy, even in the best of times. So we just come out of COVID we have financial situations, which are don't make things challenging. And I'll steal a quote from Andy Grove, which you've all heard, but it's that bad companies are destroyed by crisis, good companies make it. But but really good companies can thrive from it. And there's a reason that you've all been invited here. We really admire what it is that you're working on, and the leadership and the path that you're taking. So maybe I've made it sound worse than it is. So I'm just going to start there. How tough is it out there? What is what is the climate like? And we'll we'll work back again, what's the climate? Like? Am I overblowing it? Or is it? Is it challenging?


 


Berk Tas  7:28  


I don't think you're overblowing it. It look, raising capital is tough to begin with, it's hand to hand combat. Right in, and it doesn't always go the way you like rarely does. And it requires entrepreneurs to be very creative. And, you know, you have the attention of a potential whether it's venture capital or someone with money, who is interested in your company, you have heard their attention for a short amount of time. And they're inundated with other stories. So it's hard as it is. And I think what's happened now is a lot of the alternative capital that came into early stage, funding has come out due to the market situation, the you know, what happened with the stock markets, and alternative investments have gained more traction like some people are weighing Should I put my money in venture or should I buy more gold? So there's some of these alternative investments that was in or crossover funds? And they're taking a step right now. So the short answer I would say is it's it's you didn't over blow it out of proportion. But it also provides opportunity because the people you're working with the potential investors you're speaking to, are actually in it for the real reasons that you're in it. So it reduced opportunity. But if you're able to find them, they're they're looking for deals too. And they want to work with amazing companies. Yes, they're more selective. There's no doubt about that. But if you're able to get yourself it requires some differentiation from the crowd. Then what I found is you're working with real believers who are in this for the long haul. They've seen the cycles, they understand this is going to come and go they're not panicking, and they believe in your technology or your company. As opposed to someone I got extra money. I'll just throw it in. So I think I think you put it really well. I don't know if I would put it as good great bad. I'd probably say like if you're willing to put the work and effort and if you truly believe in what you're doing. And if you have customers who believe it then I think It's not as bad as it sounds.


 


Bryan Lord  10:04  


I'll point out a year ago, I had an investor say, I'm not interested in med tech, because I'm investing in Bitcoin. Now I hear for the first time, I'm not interested in med tech having someone investing in gold. Yeah, that's an eight year span, right? I mean, some of that is also quite tumultuous.


 


Abtihal Raji-Kubba  10:18  


Yeah. I think I'm hearing a lot more questions about maybe a lot more in depth conversations about, which is a reflection of how selective I think investors have become about, well, tell me more, why does this matter? Just a lot more deeper conversations. And so more time explaining what we're doing? I, I wouldn't say it's a hesitation as much as they are that the investors themselves are, are investing less. So they're being more selective about where they're investing. So you're getting a lot, you're getting multiple layers of questions about the same thing. And in the end, what out you know, what, at least what I've experienced recently is that the believers in what you're doing will come through, and they may ask twice, if maybe it's taking them longer the second round, but if they truly are believers in what you're doing, they'll come back.


 


Bryan Lord  11:20  


So we're fundraising to so I won't gloss over that. But I'll take a slightly different twist and talk about supply chain challenges. So you talked about a little bit of diversity on the panel, we're perhaps a little later stage, we're ready to launch in in the tail end of q4. So we're ready in the supply chain. We've got single use devices, which means you got to procure a lot of components in order to be able to ship and sell those, those single use single use kits. So we're seeing a lot of challenges there. I mean, certainly that's not overblown in terms of that, we've been fortunate and that we've been out ahead of the curve on that, to mitigate that we made a really substantial buy of some of the critical components. And we hired supply chain expertise, that really has helped us, I think, differentiate some internal capability in that way. But also, obviously mitigate the substantial risk there. So you put those two things together. Look, I've had, you know, multiple conversations today with prospective investors. And what they want to know is, you know, well, okay, classic sort of question use of proceeds and the like. And one of the things I'd like to point out speaking, as Burke had mentioned, about opportunity, I think capital likes to see that there's a direct correlation between the dollars that come in, if you will, and the impact that those can make. So I think part of the pitch to an investor is listen, if you've extinguished technology risk, if you've extinguished regulatory risk, if you believe strongly in the market, which we do that wants the product that we're developing, you can make a differentiation in terms of balance sheet strength, and then go be competitive in the marketplace to go get those those components. So good news is we know exactly where all the parts are, we know how to get them. Bad news is lead times are extraordinarily long, so you got to be out ahead of that, that takes balance sheet strength to be able to get and last point is that believe it or not, there's flippers, if you will, you know, that are squatting on on components, and then marking them up triple in commodity, you know, components or at least commodity components that in the in the normal times you would expect to be to be that way. Suggestions are that's the you know, all around the industry that the supply chain is starting to, you know, repair and fix itself as it as it is known to do. So there's some proverbial green shoots there. But that's it is a real challenge. And we've been facing it head on.


 


Carolina Aguilar  13:44  


Thank you. In our case, we were founded in 2020. So our life has been always hard. And that's great, because you know that that's the path. And at the end, we had to raise during COVID times via zoom, we had to hire during COVID times by zoom. And knowing that the purpose is common for investors, and enterpreneurs, which is saving lives, and knowing that we are here to do something more difficult and more innovative, that will exist at the end our responsibilities, find the path, find the path within the challenge, and make sure that you've built enough options and plans ABCDE. So at the end, you have a solution for the challenge you're facing. Right. So there's no other way.


 


Scott Pantel  14:35  


Okay, very good. So, let's get into it. Burke and I had a talk in the hall. I'm going to do it here. Burke. All right. We're going to be careful because we're all friends here. Okay, we're off. We're all friends here. We had a nice chat this morning. With with Dr. Bernt Montag and we talked about big problems that are out there. And what do we go after them We hear from investors we hear from strategics on what they're looking for. So I'd like to start it this way, let's make this open conversation, we can just, if you have something that's you have a burning desire, you can jump in. What do you look for in investors? What does this group look for in their board? In their partners? We hear everyone talking about the ideal entrepreneur and CEO, what's an ideal partner? For you, whether it's an investor, a board member, what are you looking for.


 


Carolina Aguilar  15:27  


So I look for complementary vision in a way that I might miss something that these people can bring to my attention, so I can evaluate it, I bring people that are constructive, this is a very long journey. So if you have painful boards, is not helpful. You know, we're here for this seven, five to 10 years, long way. So I need people that can build not destroyed, and I need challenge as well. So I don't mind toughness, I don't mind having healthy conflict. But at the end, we have to find a way come away where this is successful. So I think it's very important at the board that we also work on our self awareness that people don't come with their egos. And with, you know, we come with how humbleness and the purpose of solving the challenges and that there's a good fit of personalities that actually makes a healthy and productive board. And, you know, I wouldn't take and this sounds a little bit arrogant, but even if I would need all this money, I wouldn't take it from someone that wouldn't bring that that to the board. Because at the end, that's what's going to destroy it, eventually the company or you get fired, and then it's all right. But in in an ideal way, that's what I will look for. 


 


Scott Pantel  16:50  


So the big bag of money is not an automatic entry into the,


 


Carolina Aguilar  16:53  


I mean, with the other things, right? Because otherwise, what is what is this life for? If you have to be in pain all the time, you know, these words,


 


Scott Pantel  17:01  


We're gonna build up to the to the grand finale. What do you what are you guys looking for?


 


Bryan Lord  17:05  


Yeah, look, personal experience, I was in the semiconductor industry for a portion of my career. And we had in that particular startup that I was part of senior management, we had $5 billion funds. The board dynamic, as it turns out, was quite toxic. You had competition basically, with wise amongst the funds, you had this sort of reporting kind of dynamic, and this sort of what have you done for me lately, kind of kind of scenario. And, you know, as it was problematic for the company's functionality, and we were, you know, we're building an enterprise. And I think, you know, the, the easiest way for me to say it is an investor who wants to grab an or, you know, who recognizes that the competition is out there in the marketplace, that capital has a critical role to play, obviously, in the building of the enterprise. It provides fuel mix your metaphors as you wish but basically get in and let's help us move move forward. And there's, you know, it's not about reporting, it's not about you know, IRR, you know, targets that are being hit itself, it's ultimately about digging in and developing a differentiated enterprise and if you want to, you know, do that together, and we'd love to take the money and then, you know, row in the same direction.


 


Abtihal Raji-Kubba  18:18  


I think, for me, someone who brings in expertise is really critical, because basically we're getting I'd say free advice, but most importantly, the the the lens, they're seeing things through on their judging and making comments is is something that is exactly what we need. So they bring that to the table. But I think I would I will never say no to more money, but I will say it I say I don't want someone to reluctantly kind of come in one foot in one foot out and you know, want to fund the company because at the end of the day where on admission, we will have our ups and downs and we are looking for people who will be supportive, we will do the hard work. We know we believe we know what we're doing. Challenge us at a healthy level. In fact that that's that's very, that's the best thing you could do for us is challenge us, but for the purpose of elevating our game, not for the purpose of doubting what we're doing. So I think I look at the board as the people who are part of the team. Their roles are slightly different, but they are definitely they need to be part of the team. I would want not want to see them differently. 


 


Berk Tas  19:35  


I try I'll try to I, there's a lot of the stuff is already said. I'll try to add to it. I think for me, I feel like the best experiences I've had in my past has been with investors who have empathy, who care about A customer you're trying to serve, they have a level of understanding of the patient population, or the physicians that we serve. And, and or curiosity about us. So everyone's trying to make money, and I won't take anyone, I won't judge anybody for that. That's fair. And that's fine. We're in a capitalistic market that's appropriate. I think, to me, the most successful way to do that, and to partner with someone is a customer obsession. And what I found the most value is you have an investor who is also obsessed in your customer, who cares about them deeply, they don't have the time to learn everything about them. But they care about us. And they have the questions around the customer and how you serve them, because I believe, and the I've seen this workout, I do believe if you serve your customer, the patient or the or the physician, you're going to be successful. Right. And then there's other customers like the administrators, and how you charge economics, we all know that, you know, there's spreadsheets to do, there's a lot of grinding work to do. And that all, look, we're all here, we kind of know how to do that, right? That's kind of pay to play, you don't get to do this, if you don't know how to do that. So I don't necessarily worry that much about it. If they have an opinion, you know, I'd rather you have you do the budget this way or that way, I don't really care. I'm fine either way. But let's serve the customer. And that, to me is the best partnerships, that people who care about it. And I think what's hard, for me at least, is when you have people who want to go into a field, who wants to appear as though they understand it, and they got money, but they don't really understand the customer. They don't get it at all. And as an entrepreneur, it's really easy at times for me to agree with an egregious opinion about how to serve that customer that they don't know anything about. That's where I think the rubber meets the road. For you have to say before, look, that's not how that works. Right? We can learn to customer, I can teach you or you can go out. But you're not on the right track, or at least we're not an agreement. I think that's where it meets the rubber meets the road. You know, I won't say no to an investor, but I think it's an alignment situation. Are you aligned on the mission or not?


 


Bryan Lord  22:32  


Look, the spotlight. First word in the in the description is leadership. Right. And I think that a lot of times in the early stages of our careers, we think about boards as being kind of in this parenting role, right, that he's sort of got a report card, and that, you know, your your monthly check ins and how you're doing on all of your, you know, KPIs and the like. And I think that's not leadership to think about the organizational structure in that way that's really delegating to folks that are a degree of separation away from, as you mentioned, the customer and strategy. And to be in a mode where you're trying to, you know, please in that environment misses the obligation of leadership, I think the whole goal is to basically set the course, have a check and balance. Hughes, as you mentioned, the the resource to check in, we all have blind spots. But ultimately, you know, the way I think about it, in spite of the fact that you have you have this sort of organizational hierarchy, you know, our job is to be the captain of the of the ship and to be pushing, pushing forward on that. And I think that's a common mistake for particularly early or first time CEOs. Yeah,


 


Abtihal Raji-Kubba  23:42  


and maybe it maybe I'm asking for too much. But I do believe there's a trust relationship that has to be built between the you know, the company and the investors. And I, you know, as exactly just like, as you explained, right now, it's at the end of the day, you either Trust me, I can do the job, or you don't but, and that needs to be established upfront. I do believe listen, I mean, just working with my own team, I do believe there are many things they know. And I trust them. So that relationship is just we have to build on that model. Because ultimately, these are the most successful teams no matter where you put them.


 


Scott Pantel  24:17  


Okay, so we just talked about a couple of things as a perfect segue. So the title leadership, innovation, raising capital in a challenging market, this, there's a lot to do. It's a lot to do. And I often sit back. And I'll wonder I see CEOs of these innovative companies out spending so much time raising the capital of doing the things we're doing here. But we forget sometimes that you're still running a company and you're still innovating and you still have people you have teams that depend on you. And we this morning, we got to talk to burn montage 60,000 plus employees. That's a big organization but a lot of resources available to him. So it's a different, a different challenge there. How do you do it? How do you balance it? Do you ever find yourself on the wrong side? of the mix where you have to shift back. So it's a very open ended question, but it's more of a recognition for you here. How do you do it? How do you balance it all? We'll start with Brian.


 


Bryan Lord  25:12  


So we're just chatting about, you know, getting on stage, right, we've all been on stage many times, and I was just saying, you know, to put me on the spot, because he knew exactly the conversation we had in the hall, I felt terrible this morning, like I got up and just was, you know, just was not on my game and got to, you know, give a presentation, given the presentation 100 times. And, you know, you guys were in the audience, hopefully, it didn't show but it just was not, you know, it didn't feel like I was on my game. So some of it is just actually kind of powering through that, look, you know, we're in different time zones. at a board meeting, that I did not really think through that we wanted to keep on the schedule, but turns out, I was seven, you know, hours ahead of that with an evening board meeting a couple of days ago. So you're just upside down. So you got to, you know, put your head down and keep going. But I think you got to also give yourself a little grace and say, hey, you know, not every presentation that you're going to give Are you going to feel like you hit the bull's eye each time. And, you know, you give yourself some some latitude in those areas. at a different stage in my career, I might have, you know, beat myself up for something that clearly no by hope nobody necessarily sort of, you know, critiques you for that kind of stuff inside, you know, you say you got something to do and next to got, you know, staff to check in with you got emails to return investors to chat with folks to meet in the lobby me just, you know, keep plucking. So, that's not necessarily inspirational, but I think it's practical that, you know, there, there's, there's work to do. And so you just keep powering through.


 


Scott Pantel  26:48  


How do you do it?


 


Carolina Aguilar  26:48  


Well, first, I think you have to build the culture, because otherwise the culture will by itself. Right. And, and building the culture, for me is not a top down approach. I think culture is about trust, and it's about values. So then you have to build it with the people you work with. But you have to do it. So if you forget about it, then is when travel happens. So my biggest obsession is, is to have a committed group of people that share the purpose and half the culture that we have, who hire who we fire who promote, it is very important, it has to be very diligently treated. And then of course, as part of that we actually build this key contribution. So we don't call them goals, because at the end is a contribution, this is 010 sum game. So either we all win on the Euler way or lose, you know, isn't there's not going to be a co winner and a C do loser. So we have to build these key contributions that add up to the goals of the company. And we call our coding, so we know exactly where we are. And they are public to the whole organization. So everybody can see who's right, who's green, and what is what we need to still do to meet those goals. So so that already get us the people and the goals together. And then of course, there are always surprises, challenges you have to deal with. But at least you know that that everybody knows how to behave, what are the goals? And what is the operational mechanism to get what we need, we also put all those goals in the office and online because we are hybrid. So everybody is very clear about what are we here for what is what we have to achieve. So that helps because it's not me just doing it is everybody doing it at the same time, so I don't have to chase people because it's it's all there public for everybody. So it helps for challenge management.


 


Scott Pantel  28:45  


Anybody want to add that?


 


Abtihal Raji-Kubba  28:46  


Yeah, I think at least I can say for my team, as I think like Carolina described, my team is smaller. But I mean, there's clarity on what we need to do here. So there's never, you know, there's never doubt about what is on critical paths and what needs to happen. So whether I'm there or not, it's happening. Now, if you ask me practically, we're a small team, they would the team, I mean, I would feel really good about helping them on daily basis to move things along and, you know, have my hands deeper into everything compared to going out and, you know, raising funds. However, just like I trust my team that they are executing to the plans, we've agreed to making sure everything on critical path is happening. They've entrusted me with doing this reaching out to the investor community and making sure we are we have this continuation, you know, continuity with the company. So it is you can ask me, Is it the best use of time I have to tell you, there are days I says the best use of my time today, and there are days I say oh my gosh, I need to go and help the team get over this or that. So depending on the day, I probably have a different Ask her for you what at the end of the day, I do know both of them are important. I trust the team, they'll do what they need to do. I trust that a building relationships with investors and future investors is part of the story. So and I need to so we need to build that part of the team the same time.


 


Berk Tas  30:19  


Yeah, I think that one piece, I would add, my personal experience I, I find the the teams that can do this kind of work, where the CEO is out fundraising a lot of the times and some of the context doesn't get back to the team, because Bernd made a great point, right, he gets to speak to the president of Kenya, I don't get to speak the president of Kenya. But I talked to the customers, I talked to investors, I have a different view of what the field wants to see. I can't download all that constantly. But what I find that helps is you hire a team that knows how to learn, and makes learning a big objective. And I don't mean, you know, they take classes or going to school or whatever, it's, it's this mentality of, there's no such thing as pass or fail. There's just a way to learn, and you learn faster than anyone else. The reason we get to do amazing things with low, we got the FDA clearance on a world's first device for $7 million. The reason you get to do that is your people know how to learn. And they learn faster than anyone else. And there's no politics, because there's a mission to accomplish. So that is what I would add is yes, team is actually important. For me, the ingredient comes from finding people who value learning, they're not anxious about not knowing the answer. And a lot of people are. So this kind of business isn't great for everybody. You know, I've seen people, their lives just struggle, and they're having a horrible time and a startup, everyone's having fun. But they're having a horrible time, because the unknown is really painful for them. So I think that was the insight, I would share from my personal experience. To add the color to what everyone says,


 


Scott Pantel  32:18  


That's great. Let's add to that the whole finding people thing we we briefly talked about it this morning about a limited amount of resources that are out there. We talked about it again, in a panel today. I know that there's different models, Brian has an interesting model, both internal and external. I'm sure we depend on people outside of organism but how is it right now? Is the how's the talent pool out there? Is it the same? Is it the same? Is it getting more challenging in general, our the human resources out there all come back to the people we talked about so much. But it all comes back to the team and the people, how's it going out there with respect to your teams and finding new people.


 


Carolina Aguilar  32:54  


So what we have done is go where the talent is, and not pretend that every talented people is where we are. Right? So that's the first principle just if they are in US, they're in US if they're in Malaysia, they're in Malaysia. And as a result of the 48 people that we have, we have people from 14 Different countries working remote and on site. Because, yeah, the world, I mean, we I cannot serve a team that is going to build the most revolutionary metric from Barcelona, that will be unrealistic. So and then you have to find these people that fit the culture, you want to build, that they have the continuous learning, they have the hunger. So you know, the filtering gets a little bit tougher, but eventually, also with great recruiters that are here as well. You make it


 


Scott Pantel  33:47  


There's a few here. 


 


Carolina Aguilar  33:48  


Exactly. And when Yeah, we need help. But if you know what you want you you get it, it's just that it's not right there around the corner.


 


Bryan Lord  33:59  


We followed a similar model. Dave, my colleague who's here, borrow his phrase, we started using Zoom before using Zoom was cool. So we had this distributed model where you basically bring on folks on your team where they are, as opposed to relocating them to the greater Boston area. We also have used the technique, this is not my phrase, either. So two borrowed phrases hired by an audition. I don't know who to attribute that to. But we've used that effectively. We have found that not only with the willingness to have some geographical diversity, but a really effective way for us to have scaled over the course of the development of pristine is to engage high quality professionals but on a fractional basis. So you start out get to know each other, you might engage as a consultant for you know, a day a week, and maybe that's the right configuration and you continue in that sort of in the in the US vernacular in that 1099 kind of fashion for Due to time and you know, definitely or you, you know, say, Hey, we've kind of run our course on things. Oftentimes, what's happened is that those types of relationships expand. And as long as you have an open dialogue with the other party and say, Listen, when we start to get too overwhelming, what the engagement is in what our deal is, let's tweak it, and let's, let's adjust it. And so we've gone with folks where we've had, you know, a couple of hours a month to now you know, full time w two is, and I think that's reduced the uncertainty in the sort of binary form of hiring where, you know, you're either gonna go through an entire interview process, and it lowers the risk around that. So tip that's that's worked very well, for us.


 


Carolina Aguilar  35:42  


Only thing is that that requires, we also upgrade our leadership skills, I don't think it's the same to deal with what we know than with word, it's new, and that, that they said de learning, which is the hardest, it's harder to learn than learn.


 


Abtihal Raji-Kubba  35:59  


I think making sure that whoever you hire, understand this is not the corporate world you're moving into this is a startup. And oh, my goodness, I've seen the difference. I mean, and again, I ran.


 


Scott Pantel  36:10  


How many years at bark?


 


Abtihal Raji-Kubba  36:12  


20 years. And Bard was decentralized. So it wasn't a large corporation. BD was very big company. But I ran Nutanix, which was a startup we acquired by CR Bard. And it was a very small company to try integrate them into, you know, the the larger corporation, you see the differences. But the only way, the only reason those tonics was very successful is because we maintain that entrepreneurial, you know, environment, and we decided, no, we're only hiring people from startups to join Nutanix. Because you've got to maintain that spirit of we're going to go out and do it. Yes, it hasn't been done. And we're going to put the hours and we will be successful.


 


Berk Tas  36:53  


One point, I will add a quote, Joe here, bring in force multipliers. I think that's a huge, huge component of hiring, you know, you got to educate your board, I think, where there's this notion of salary bands and things like that there are boxes and people fit in these nice boxes. And, look, you're not creating a box, you're building something that no one has done. Forget about the boxes, right? Who who is going to allow you to attract more talent, who's passionate about your vision, obviously, talent has to be there. And you're going to pull these people from a different job. Right? So I think we as CEOs need to go to bat and say, I don't really care about not in this way, do it far more elegantly, plus, your bands or whatever you have, on your mind, forget those. And understand that we're building something that when you put one, you're going to get 358 In return, and those people are going to attract other talented people, because look talented people want to work with talented people, period.


 


Bryan Lord  38:08  


I think I like that phrase, the force multiplier, I think that's exactly right. Equally important, are doers. There's no opportunity for middle management. No, really no opportunity for upper management, a lot of ways when you look at you know, having absolutely your own slide decks, it's just 100% of growth that needs to be done, right. And so if you have people that are interested in, you know, hierarchy and structure and, you know, delegation and reporting that's not consistent with hustle with doing. And I think that DNA to me is far more important. It doesn't matter background look, we'd love to have folks come in from this week, as we have, you know, Stryker and Medtronic and others. But the common thread is, you know, there's no ceremony, there's, you know, but get stuff done. And that means rolling up your own sleeves.


 


Berk Tas  38:58  


Now, I always think of it like a SEAL team. It's very focused, very small, but even the medic knows how to go to battle. So it's not the, you know, the army ship where there's army cook, and that's what they do. You can't have that. In a startup. You got to have people who are specialized understand the mission have been training their whole lives, even if you bring a junior person, right. They've been living, they've been growing, they know how to learn, and they're part of that mission. They can pick up a shovel when the time comes. 


 


Scott Pantel  39:29  


Very good. So I want to I want to end with something practical. I've been joking since last night a little bit with the Sofinnova conversation that we had, they have 2.5 billion assets under management management. And we've got 100 companies here that are raising about 2.5 billion. We talk about you know, money comes in, what do we get out? You've all been invited here because you're incredible innovators, and we really believe in what you're doing here. So we know that you're going to achieve your goals. Let's, we can jump in whoever wants to jump in first, what's your current? Let's be practical here. What's your current capital raise situation? And where does it get the company? You get what you're going for today? Where can it take your company? What does an investor see? In your in your development.


 


Carolina Aguilar  40:17  


Yeah. So we have one more year of cash. So we wanted to get the right people on board. And with that, we are going to put graphene in the brain of a human being for the first time in the world. So we know that that's going to bring the material to the next level, we already know the potential, and what it gives us and the safety that it brings. So it's very exciting to see it in action in, in helping someone with a tumor, for instance, in our case, and also subcortical II. So that's the only thing we're focusing on bringing that first thing human in.


 


Bryan Lord  40:55  


Right? Yeah, so we're raising a $10 million extension on our on our current round, that will accelerate our platform expansion. So I mentioned that we're launching an arthroscopy, but we already have a single use laparoscope, as well as a single use flexible platform that's under development. And so we can modulate a bit, you know, in terms of applying new capital to platform expansion. But that will accelerate basically our moves into those additional new markets. And so that's a priority for us right now, because we think that's a competitive advantage. So if we were to be sticking to our knitting and thinking as as sort of a one trick pony, if you will, and single product company, we'd be thinking a whole lot more conservatively about capital raising. Now, that might be what's called for, it seems in this crazy capital raising environment. But we also think, look, you know, there's 200 reports are $270 billion of capital that's sitting allocated from the limited partners, it's sitting in the hands of general partners throughout all sectors right in the marketplace. And that capital, you know, needs to find a home, by the same token, so it's a strange, you know, dynamic. I think, if you tell a story, that's a compelling story, and you're committed to that that sort of vision, there is on the flip side of this challenging capital raising environment, the the numbers are real, there's a lot of capital there. And so that's a strange duality that we find ourselves in here at the tail end of 2022. So you know, our mission is to do both, it's to be sort of judicious. But then also, you know, show the vector that we're heading to. And I think that investors want to see a big vision at the same time,


 


Abtihal Raji-Kubba  42:43  


We're raising 10 million series, a 5 million of it is committed, and what that will do will actually get the product approved and available to female patients out there. That will take us through the IDE denovo clinical trial on FDA approval.


 


Berk Tas  43:02  


Thank you. I want to thank you. For one thing, if I don't get a chance, thanks for also putting together a diverse panel, women and men, I appreciate that. I have a daughter, and I've been more interested in this topic lately. I should probably have been always but I have a small


 


Scott Pantel  43:20  


Get on it, Burke.


 


Berk Tas  43:22  


So I wanted to thank you. 


 


Scott Pantel  43:24  


My pleasure. 


 


Berk Tas  43:25  


We're raising up to six, we're at 4.2 right now. And by the time we're done spending the money we raised, we will prove that people use what we developed, and they buy it. We're targeting 30 centers initially. And we'll have more publications to clearly articulate the benefits we provide. And then the next step from there, either is going into m&a or raising a scale round with multiple partners.


 


Scott Pantel  43:59  


Very good. Well, I want to thank all of the CEOs up here who are out there innovating making the world better place thanks for the event is you the event the content is is all of you that are out there taking chances. It's an honor to be on stage with you, when I encourage everybody to get to know the CEOs more and thank you for joining us this afternoon.


 

back Back to all attendees close
Carolina Aguilar

Carolina Aguilar

CEO, InBrain Neuroelectronics

Neuroscientist and Business Executive with 15+ years of Medtech experience managing complex environments from acquisitions to consolidated businesses with P&Ls up to $140M all with high single to double digit growth % YOY. Head of Medtronic Deep Brain Stimulation for 10 years both as the European sales director and Global commercialization lead. Lover of value-based healthcare innovation leading to healthcare sustainability.

  • linkedin
  • Website website
back Back to all attendees close

Carolina Aguilar

CEO, InBrain Neuroelectronics

Neuroscientist and Business Executive with 15+ years of Medtech experience managing complex environments from acquisitions to consolidated businesses with P&Ls up to $140M all with high single to double digit growth % YOY. Head of Medtronic Deep Brain Stimulation for 10 years both as the European sales director and Global commercialization lead. Lover of value-based healthcare innovation leading to healthcare sustainability.

  • linkedin
  • Website website
Carolina Aguilar
back Back to all attendees close
Bryan Lord

Bryan Lord

CEO, Pristine Surgical

Mr. Lord works with start-ups and investors to bring new med-tech, high-tech, clean-tech, and software products to the market and to help companies scale. He has experience as an executive, entrepreneur, advisor, deal facilitator, and investor.

  • linkedin
  • Website website
back Back to all attendees close

Bryan Lord

CEO, Pristine Surgical

Mr. Lord works with start-ups and investors to bring new med-tech, high-tech, clean-tech, and software products to the market and to help companies scale. He has experience as an executive, entrepreneur, advisor, deal facilitator, and investor.

  • linkedin
  • Website website
Bryan Lord
back Back to all attendees close
Abtihal Raji-Kubba

Abtihal Raji-Kubba

CEO, Empress Medical

A global minded Medtech Executive General Manager, President, CEO and COO with a track record of leading cross-functional teams to develop and launch game-changing products in record short times. Transform divisions and subsidiaries, expand New Product Development portfolios, and drive global product launches. Create vision and strategy, re-define markets, identify opportunities, and deliver business turnarounds achieving significant new revenue streams.

  • linkedin
  • Website website
back Back to all attendees close

Abtihal Raji-Kubba

CEO, Empress Medical

A global minded Medtech Executive General Manager, President, CEO and COO with a track record of leading cross-functional teams to develop and launch game-changing products in record short times. Transform divisions and subsidiaries, expand New Product Development portfolios, and drive global product launches. Create vision and strategy, re-define markets, identify opportunities, and deliver business turnarounds achieving significant new revenue streams.

  • linkedin
  • Website website
Abtihal Raji-Kubba
back Back to all attendees close
Berk Tas

Berk Tas

CEO, SentiAR

Berk serves as the Chief Executive Officer and President of SentiAR. Berk has led development of emerging technologies and companies in Fortune 500, private equity, venture capital funded and privately held organizations. Prior to joining SentiAR he led the development of a novel Trans-aortic Valve Replacement technology into CE Mark studies at HLT Medical. In 2016, he played an integral role in the acquisition of Sensium, Oxford UK, a novel wireless monitoring technology. Prior to that he served in various leadership roles at Sunshine Heart developing a first of its kind, heart failure therapy and at Boston Scientific developing several novel therapies and technologies focused in Cardiac Rhythm Management. He holds an MBA from the Carlson School of Business at the University of Minnesota and a BS in Electrical Engineering and Physics from the School of Engineering at St Thomas University.

  • linkedin
  • Website website
back Back to all attendees close

Berk Tas

CEO, SentiAR

Berk serves as the Chief Executive Officer and President of SentiAR. Berk has led development of emerging technologies and companies in Fortune 500, private equity, venture capital funded and privately held organizations. Prior to joining SentiAR he led the development of a novel Trans-aortic Valve Replacement technology into CE Mark studies at HLT Medical. In 2016, he played an integral role in the acquisition of Sensium, Oxford UK, a novel wireless monitoring technology. Prior to that he served in various leadership roles at Sunshine Heart developing a first of its kind, heart failure therapy and at Boston Scientific developing several novel therapies and technologies focused in Cardiac Rhythm Management. He holds an MBA from the Carlson School of Business at the University of Minnesota and a BS in Electrical Engineering and Physics from the School of Engineering at St Thomas University.

  • linkedin
  • Website website
Berk Tas
back Back to all attendees close
Scott Pantel

Scott Pantel

CEO, LSI

Scott is the President, CEO and Founder of Life Science Intelligence.  He has been in the medtech market intelligence business for over 20 years supporting venture funded startups, major strategics, and life science investors as they navigate the ever-changing medtech marketplace.  Prior to founding LSI, he held senior executive roles with renowned life science data providers including Medical Data International, Medtech Insight and Windhover Information.  He has held leadership roles as a strategic partner for Elsevier Business Intelligence, Health Research Intelligence, and Informa Business Intelligence.  Scott and his team at LSI have conducted numerous market research projects for top medical device manufacturers including Johnson & Johnson, Medtronic, Boston Scientific, Abbott, Becton Dickinson, Teleflex, Cardinal Health, GE Healthcare, and Stryker, among others.   

  • linkedin
  • Website website
back Back to all attendees close

Scott Pantel

CEO, LSI

Scott is the President, CEO and Founder of Life Science Intelligence.  He has been in the medtech market intelligence business for over 20 years supporting venture funded startups, major strategics, and life science investors as they navigate the ever-changing medtech marketplace.  Prior to founding LSI, he held senior executive roles with renowned life science data providers including Medical Data International, Medtech Insight and Windhover Information.  He has held leadership roles as a strategic partner for Elsevier Business Intelligence, Health Research Intelligence, and Informa Business Intelligence.  Scott and his team at LSI have conducted numerous market research projects for top medical device manufacturers including Johnson & Johnson, Medtronic, Boston Scientific, Abbott, Becton Dickinson, Teleflex, Cardinal Health, GE Healthcare, and Stryker, among others.   

  • linkedin
  • Website website
Scott Pantel